|
|
 | | | |
- close
- close
- close
- close
FiercePharma
2 hrs ago
Comment
Novartis is one step closer to knowing how its latest round of Zometa litigation works out. After 11 days of testimony, the jury has started deliberating its verdict on plaintiff Beverly Meng's claims that the Swiss drugmaker downplayed the bone...
The Economic Times
May 14
Comment
Novartis India on Tuesday reported a 25.82 per cent dip in its net profit to Rs 24.41 crore for the quarter ended March 31, 2013.
The Hindu Business Line
May 13
Comment
Novartis India has announced the next edition of the Novartis Biotechnology Leadership Camp (BioCamp) taking place in Hyderabad from July 8-10, 2013.
BioCamp is a seminar orga...
MedPage Today
May 10
Comment
(MedPage Today) -- Ilaris, a monoclonal antibody targeting interleukin-1beta, has been approved for the treatment of systemic juvenile idiopathic arthritis), the manufacturer announced.
FiercePharma
May 10
Comment
Novartis has grabbed one of two new indications it was shooting for with its rare disease drug Ilaris, one step toward turning the drug into a blockbuster.
Forbes
May 9
Comment
In recent years, pharmaceutical companies have faced criminal investigations and charges in regard to alleged off-label marketing of prescription drugs and kickbacks to doctors. For this reason, the filing last month of two civil cases against...
The Economic Times
May 9
Comment
Drug major Novartis India said its Swiss promoter Novartis AG has appointed Citigroup Capital Markets as the broker for the proposed share sale.
FierceBiotech
May 6
Comment
Ever since the FDA started to anoint a short list of drug candidates as "breakthrough" therapies deserving of swift regulatory reviews, the industry has been trying to puzzle out one important question: What does it mean?
FierceBiotech
May 3
Comment
Novartis has opened an investigation after learning that a company employee was affiliated with a study of its blood pressure drug Diovan as a statistician without revealing his ties to the Swiss healthcare giant.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| |||||||
